Suppression of telomerase activity in leukemic cells by mutant forms of Rhodospirillum rubrum L-asparaginase
- 作者: Pokrovskaya M.V.1, Zhdanov D.D.1, Eldarov M.A.2, Aleksandrova S.S.1, Veselovsky A.V.1, Pokrovskiy V.S.1,3, Grishin D.V.1, Gladilina J.A.1, Sokolov N.N.1
-
隶属关系:
- Institute of Biomedical Chemistry
- Research Center of Biotechnology RAS
- Blokhin Cancer Research Center
- 期: 卷 11, 编号 3 (2017)
- 页面: 219-233
- 栏目: Article
- URL: https://journals.rcsi.science/1990-7508/article/view/197845
- DOI: https://doi.org/10.1134/S1990750817030088
- ID: 197845
如何引用文章
详细
Active and stable mutant forms of short chain cytoplasmic L-asparaginase type I of Rhodospirillum rubrum (RrA) (RrA+N17, D60K, F61L, RrA+N17, A64V, E67K, RrA+N17, E149R, V150P, RrAE149R, V150P and RrAE149R, V150P, F151T) have been obtained by the method of site-directed mutagenesis. The variants RrAE149R, V150P, F151T and RrА+N17, E149R, V150P could decrease reduce expression of the hTERT telomerase subunit and, therefore, activity of telomeres in Jurkat cells, but not in cellular lysates. At the same time, L-asparaginasеs of Escherichia coli, Erwinia carotovora, and Wolinella succinogenes, mutant forms RrА+N17, D60K, F61L and RrА+N17, A64V, E67K did not suppress telomerase activity. It is suggested that some regions in the RrA structure (amino acids residues 146–164, 1–17, 60–67) are responsible for suppression of telomerase activity. The results obtained show that antineoplastic activity of some RrA variants is associated both with reduction of concentration of free L-asparagine, and with decreased expression of the hTERT telomerase subunit; this opens new prospects for antineoplastic therapy.
作者简介
M. Pokrovskaya
Institute of Biomedical Chemistry
编辑信件的主要联系方式.
Email: ivan1190@yandex.ru
俄罗斯联邦, ul. Pogodinskaya 10, Moscow, 119121
D. Zhdanov
Institute of Biomedical Chemistry
Email: ivan1190@yandex.ru
俄罗斯联邦, ul. Pogodinskaya 10, Moscow, 119121
M. Eldarov
Research Center of Biotechnology RAS
Email: ivan1190@yandex.ru
俄罗斯联邦, Leninsky pr. 33, Moscow, 119071
S. Aleksandrova
Institute of Biomedical Chemistry
Email: ivan1190@yandex.ru
俄罗斯联邦, ul. Pogodinskaya 10, Moscow, 119121
A. Veselovsky
Institute of Biomedical Chemistry
Email: ivan1190@yandex.ru
俄罗斯联邦, ul. Pogodinskaya 10, Moscow, 119121
V. Pokrovskiy
Institute of Biomedical Chemistry; Blokhin Cancer Research Center
Email: ivan1190@yandex.ru
俄罗斯联邦, ul. Pogodinskaya 10, Moscow, 119121; Kashirskoe Shosse, 24, Moscow, 115478
D. Grishin
Institute of Biomedical Chemistry
Email: ivan1190@yandex.ru
俄罗斯联邦, ul. Pogodinskaya 10, Moscow, 119121
Ju. Gladilina
Institute of Biomedical Chemistry
Email: ivan1190@yandex.ru
俄罗斯联邦, ul. Pogodinskaya 10, Moscow, 119121
N. Sokolov
Institute of Biomedical Chemistry
Email: ivan1190@yandex.ru
俄罗斯联邦, ul. Pogodinskaya 10, Moscow, 119121
补充文件
